Poukalov Konstantin Insider Trades

Insider Trading History

Track insider trading activity for Poukalov Konstantin. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Lyra Therapeutics
Lyra Therapeutics LYRA
Director
Holding Value $13.2k 30,000 shares
Last Trade
Jun 13, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$465k 30,000 shares
$15.51
$0.44
LianBio
LianBio LIAN
Director
Holding Value $0 0 shares
Last Trade
Feb 15, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$174k 36,300 shares
$4.78
$0.32
LianBio
LianBio LIAN
Director
Holding Value $11.6k 36,300 shares
Last Trade
Feb 15, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$174k 36,300 shares
$4.78
$0.32
LianBio
LianBio LIAN
Director
Holding Value $5.45k 17,082 shares
Last Trade
Feb 15, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$91.5k 19,218 shares
$4.76
$0.32
Lyra Therapeutics
Lyra Therapeutics LYRA
Director
Holding Value $8.8k 20,000 shares
Last Trade
Jun 30, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.11M 20,000 shares
$205.50
$0.44
LianBio
LianBio LIAN
Director
Holding Value $11.6k 36,300 shares
Last Trade
Jun 21, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$87.1k 36,300 shares
$2.40
$0.32
LianBio
LianBio LIAN
Director
Holding Value $11.6k 36,300 shares
Last Trade
Jun 23, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$91.5k 36,300 shares
$2.52
$0.32
Lyra Therapeutics
Lyra Therapeutics LYRA
Director
Holding Value $3.19k 7,250 shares
Last Trade
Jun 16, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.85M 7,250 shares
$254.50
$0.44
LianBio
LianBio LIAN
Director
Holding Value $0 0 shares
Last Trade
Oct 29, 2021 Sale
No data
No data
$0.32
Lyra Therapeutics
Lyra Therapeutics LYRA
Director
Holding Value $3.19k 7,250 shares
Last Trade
May 26, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.62M 7,250 shares
$362.00
$0.44
Landos Biopharma
Landos Biopharma LABP
10% owner
Holding Value $0 0 shares
Last Trade
Feb 08, 2021 Sale (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$14.9B 13,369,728 shares
$1,112.00
$22.93
Landos Biopharma
Landos Biopharma LABP
10% owner
Holding Value $307M 13,369,728 shares
Last Trade
Feb 08, 2021 Purchase (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$14.9B 13,369,728 shares
$1,112.00
$22.93
Landos Biopharma
Landos Biopharma LABP
10% owner
Holding Value $335M 14,619,728 shares
Last Trade
Feb 08, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$1.39B 1,250,000 shares
$1,112.00
$22.93
Landos Biopharma
Landos Biopharma LABP
10% owner
Holding Value $337M 14,681,792 shares
Last Trade
Feb 08, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$38.5M 34,611 shares
$1,112.00
$22.93
Landos Biopharma
Landos Biopharma LABP
10% owner
Holding Value $336M 14,647,181 shares
Last Trade
Feb 05, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$30.3M 27,453 shares
$1,105.00
$22.93
Landos Biopharma
Landos Biopharma LABP
10% owner
Holding Value $0 0 shares
Last Trade
Feb 03, 2021 Sale
No data
No data
$22.93
Lyra Therapeutics
Lyra Therapeutics LYRA
Director
Holding Value $6.38k 14,500 shares
Last Trade
Apr 30, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$0.44

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up